Prostaglandin analog therapy challenges and innovation in glaucoma therapeutics
Glaucoma management primarily relies on prostaglandin analogs (PGAs) for effective intraocular pressure reduction. However, chronic PGA use frequently leads to ocular and periocular side effects such as conjunctival hyperemia, eyelash growth, and irreversible iris pigmentation, significantly affecti...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wolters Kluwer Medknow Publications
2026-03-01
|
| Ráidu: | Indian Journal of Ophthalmology |
| Fáttát: | |
| Liŋkkat: | https://journals.lww.com/10.4103/IJO.IJO_2387_25 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
